. . . These new stringent rules will strongly impact the pipeline of scientific talent the NIH has provided the biopharm industry.
Howard A. Young, Ph.D.
Advertisement
Articles by Howard A. Young, Ph.D.
Advertisement
Latest Updated Articles
- Final Word: NIH-Biopharm Interactions and the New NIH Conflict-of-Interest Regulations
Published: June 1st 2005 | Updated:
Advertisement
Advertisement
